z-logo
open-access-imgOpen Access
Long-term benefit of primary angioplasty compared to thrombolytic therapy for acute myocardial infarction
Author(s) -
Felix Zijlstra
Publication year - 2000
Publication title -
european heart journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.336
H-Index - 293
eISSN - 1522-9645
pISSN - 0195-668X
DOI - 10.1053/euhj.2000.2192
Subject(s) - medicine , primary angioplasty , myocardial infarction , cardiology , angioplasty , term (time) , percutaneous coronary intervention , physics , quantum mechanics
ea relative risk 0·58, 95 % confidence intervals 0·44–0·76). With respect to safety, stroke was reduced from 2·0% with thrombolysis to 0·7 % with angioplasty (relative primary angioplasty, this treatment is now preferred when logistics allow this approach. As has been shown for angioplasty for stable and unstable angina[9], it is likely that the results of primaryrisk 0·35, 95 % confidence intervals 0·14–0·77). How-ever, considerable uncertainty existed about the long-term relative merits of these two approaches. We recently published long-term follow-up data of 395 patients randomly assigned to treatment with angioplasty or intravenous streptokinase[3]. Clinical information was collected for a mean (SD) of 52 years, and medical charges were compared. A total of 194 patients were assigned to undergo angioplasty angioplasty will be, in part, dependent on the setting in which it is performed, and therefore the results from various hospitals may differ considerably[2,10]. Establishing and maintaining a proficient primary angioplasty programme takes considerable institu-tional will and effort[11,12]. Many patients with acute myocardial infarction are admitted to hospitals with-out angioplasty facilities, necessitating additional transportation to an interventional catheterizationEuropean Heart Journal (2000) 21, 1487–1489 doi:10.1053/euhj.2000.2192, available online a

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom